Progressive Multifocal Leukoencephalopathy after Ibrutinib Therapy for Chronic Lymphocytic Leukemia

Progressive multifocal leukoencephalopathy (PML) is a devastating neurological disease observed nearly exclusively in immunocompromised patients. Recently, the introduction of monoclonal antibodies significantly inhibiting the immune system such as rituximab has led to an increase in PML cases. Alth...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer Res Treat
Hauptverfasser: Lutz, Mathias, Schulze, Arik B., Rebber, Elisabeth, Wiebe, Stefanie, Zoubi, Tarek, Grauer, Oliver M., Keßler, Torsten, Kerkhoff, Andrea, Lenz, Georg, Berdel, Wolfgang E.
Format: Artigo
Sprache:Inglês
Veröffentlicht: Korean Cancer Association 2017
Schlagworte:
Case Report
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5398396/
https://ncbi.nlm.nih.gov/pubmed/27456945
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2016.110
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge